The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Dravet Syndrome Treatment Market Research Report 2025

Global Dravet Syndrome Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1426884

No of Pages : 82

Ask Your Query

Synopsis
Market Analysis and Insights: Global Dravet Syndrome Treatment Market

Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells.

The global Dravet Syndrome Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include clobazam (Onfi, Frisium) and valproic acid (Depakote, Depakene). Second line treatments include stiripentol (Diacomit), topiramate (Topamax), and the ketogenic diet.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dravet Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dravet Syndrome Treatment market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dravet Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dravet Syndrome Treatment market.

Global Dravet Syndrome Treatment Scope and Market Size
Dravet Syndrome Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Dravet Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • First-generation Drug (FGD)
  • Second-generation Drug (SGD)
  • Third-generation Drug (TGD)

Segment by Application

  • Hospital Pharmacy
  • Retail Pharmacy
  • E- Commerce
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Biocodex
  • Epygenix Therapeutics
  • Gw Pharmaceuticals
  • Opko Health
  • Zogenix
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dravet Syndrome Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 First-generation Drug (FGD)
1.2.3 Second-generation Drug (SGD)
1.2.4 Third-generation Drug (TGD)
1.3 Market by Application
1.3.1 Global Dravet Syndrome Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 E- Commerce
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Dravet Syndrome Treatment Market Perspective (2017-2028)
2.2 Dravet Syndrome Treatment Growth Trends by Region
2.2.1 Dravet Syndrome Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Dravet Syndrome Treatment Historic Market Size by Region (2017-2022)
2.2.3 Dravet Syndrome Treatment Forecasted Market Size by Region (2023-2028)
2.3 Dravet Syndrome Treatment Market Dynamics
2.3.1 Dravet Syndrome Treatment Industry Trends
2.3.2 Dravet Syndrome Treatment Market Drivers
2.3.3 Dravet Syndrome Treatment Market Challenges
2.3.4 Dravet Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dravet Syndrome Treatment Players by Revenue
3.1.1 Global Top Dravet Syndrome Treatment Players by Revenue (2017-2022)
3.1.2 Global Dravet Syndrome Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Dravet Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dravet Syndrome Treatment Revenue
3.4 Global Dravet Syndrome Treatment Market Concentration Ratio
3.4.1 Global Dravet Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dravet Syndrome Treatment Revenue in 2021
3.5 Dravet Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Dravet Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Dravet Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dravet Syndrome Treatment Breakdown Data by Type
4.1 Global Dravet Syndrome Treatment Historic Market Size by Type (2017-2022)
4.2 Global Dravet Syndrome Treatment Forecasted Market Size by Type (2023-2028)
5 Dravet Syndrome Treatment Breakdown Data by Application
5.1 Global Dravet Syndrome Treatment Historic Market Size by Application (2017-2022)
5.2 Global Dravet Syndrome Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Dravet Syndrome Treatment Market Size (2017-2028)
6.2 North America Dravet Syndrome Treatment Market Size by Country (2017-2022)
6.3 North America Dravet Syndrome Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Dravet Syndrome Treatment Market Size (2017-2028)
7.2 Europe Dravet Syndrome Treatment Market Size by Country (2017-2022)
7.3 Europe Dravet Syndrome Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dravet Syndrome Treatment Market Size (2017-2028)
8.2 Asia-Pacific Dravet Syndrome Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Dravet Syndrome Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Dravet Syndrome Treatment Market Size (2017-2028)
9.2 Latin America Dravet Syndrome Treatment Market Size by Country (2017-2022)
9.3 Latin America Dravet Syndrome Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dravet Syndrome Treatment Market Size (2017-2028)
10.2 Middle East & Africa Dravet Syndrome Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Dravet Syndrome Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Biocodex
11.1.1 Biocodex Company Detail
11.1.2 Biocodex Business Overview
11.1.3 Biocodex Dravet Syndrome Treatment Introduction
11.1.4 Biocodex Revenue in Dravet Syndrome Treatment Business (2017-2022)
11.1.5 Biocodex Recent Development
11.2 Epygenix Therapeutics
11.2.1 Epygenix Therapeutics Company Detail
11.2.2 Epygenix Therapeutics Business Overview
11.2.3 Epygenix Therapeutics Dravet Syndrome Treatment Introduction
11.2.4 Epygenix Therapeutics Revenue in Dravet Syndrome Treatment Business (2017-2022)
11.2.5 Epygenix Therapeutics Recent Development
11.3 GW Pharmaceuticals
11.3.1 GW Pharmaceuticals Company Detail
11.3.2 GW Pharmaceuticals Business Overview
11.3.3 GW Pharmaceuticals Dravet Syndrome Treatment Introduction
11.3.4 GW Pharmaceuticals Revenue in Dravet Syndrome Treatment Business (2017-2022)
11.3.5 GW Pharmaceuticals Recent Development
11.4 OPKO Health
11.4.1 OPKO Health Company Detail
11.4.2 OPKO Health Business Overview
11.4.3 OPKO Health Dravet Syndrome Treatment Introduction
11.4.4 OPKO Health Revenue in Dravet Syndrome Treatment Business (2017-2022)
11.4.5 OPKO Health Recent Development
11.5 Zogenix
11.5.1 Zogenix Company Detail
11.5.2 Zogenix Business Overview
11.5.3 Zogenix Dravet Syndrome Treatment Introduction
11.5.4 Zogenix Revenue in Dravet Syndrome Treatment Business (2017-2022)
11.5.5 Zogenix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Dravet Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of First-generation Drug (FGD)
Table 3. Key Players of Second-generation Drug (SGD)
Table 4. Key Players of Third-generation Drug (TGD)
Table 5. Global Dravet Syndrome Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Dravet Syndrome Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Dravet Syndrome Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Dravet Syndrome Treatment Market Share by Region (2017-2022)
Table 9. Global Dravet Syndrome Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Dravet Syndrome Treatment Market Share by Region (2023-2028)
Table 11. Dravet Syndrome Treatment Market Trends
Table 12. Dravet Syndrome Treatment Market Drivers
Table 13. Dravet Syndrome Treatment Market Challenges
Table 14. Dravet Syndrome Treatment Market Restraints
Table 15. Global Dravet Syndrome Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Dravet Syndrome Treatment Market Share by Players (2017-2022)
Table 17. Global Top Dravet Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dravet Syndrome Treatment as of 2021)
Table 18. Ranking of Global Top Dravet Syndrome Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Dravet Syndrome Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dravet Syndrome Treatment Product Solution and Service
Table 22. Date of Enter into Dravet Syndrome Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dravet Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Dravet Syndrome Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Dravet Syndrome Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Dravet Syndrome Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Dravet Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Dravet Syndrome Treatment Revenue Market Share by Application (2017-2022)
Table 30. Global Dravet Syndrome Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Dravet Syndrome Treatment Revenue Market Share by Application (2023-2028)
Table 32. North America Dravet Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Dravet Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Dravet Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Dravet Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Dravet Syndrome Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Dravet Syndrome Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Dravet Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Dravet Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Dravet Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Dravet Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 42. Biocodex Company Detail
Table 43. Biocodex Business Overview
Table 44. Biocodex Dravet Syndrome Treatment Product
Table 45. Biocodex Revenue in Dravet Syndrome Treatment Business (2017-2022) & (US$ Million)
Table 46. Biocodex Recent Development
Table 47. Epygenix Therapeutics Company Detail
Table 48. Epygenix Therapeutics Business Overview
Table 49. Epygenix Therapeutics Dravet Syndrome Treatment Product
Table 50. Epygenix Therapeutics Revenue in Dravet Syndrome Treatment Business (2017-2022) & (US$ Million)
Table 51. Epygenix Therapeutics Recent Development
Table 52. GW Pharmaceuticals Company Detail
Table 53. GW Pharmaceuticals Business Overview
Table 54. GW Pharmaceuticals Dravet Syndrome Treatment Product
Table 55. GW Pharmaceuticals Revenue in Dravet Syndrome Treatment Business (2017-2022) & (US$ Million)
Table 56. GW Pharmaceuticals Recent Development
Table 57. OPKO Health Company Detail
Table 58. OPKO Health Business Overview
Table 59. OPKO Health Dravet Syndrome Treatment Product
Table 60. OPKO Health Revenue in Dravet Syndrome Treatment Business (2017-2022) & (US$ Million)
Table 61. OPKO Health Recent Development
Table 62. Zogenix Company Detail
Table 63. Zogenix Business Overview
Table 64. Zogenix Dravet Syndrome Treatment Product
Table 65. Zogenix Revenue in Dravet Syndrome Treatment Business (2017-2022) & (US$ Million)
Table 66. Zogenix Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dravet Syndrome Treatment Market Share by Type: 2021 VS 2028
Figure 2. First-generation Drug (FGD) Features
Figure 3. Second-generation Drug (SGD) Features
Figure 4. Third-generation Drug (TGD) Features
Figure 5. Global Dravet Syndrome Treatment Market Share by Application in 2021 & 2028
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. E- Commerce Case Studies
Figure 9. Others Case Studies
Figure 10. Dravet Syndrome Treatment Report Years Considered
Figure 11. Global Dravet Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Dravet Syndrome Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Dravet Syndrome Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Dravet Syndrome Treatment Market Share by Players in 2021
Figure 15. Global Top Dravet Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dravet Syndrome Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Dravet Syndrome Treatment Revenue in 2021
Figure 17. North America Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Dravet Syndrome Treatment Market Share by Country (2017-2028)
Figure 19. United States Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Dravet Syndrome Treatment Market Share by Country (2017-2028)
Figure 23. Germany Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Dravet Syndrome Treatment Market Share by Region (2017-2028)
Figure 31. China Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Dravet Syndrome Treatment Market Share by Country (2017-2028)
Figure 39. Mexico Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Dravet Syndrome Treatment Market Share by Country (2017-2028)
Figure 43. Turkey Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Dravet Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Biocodex Revenue Growth Rate in Dravet Syndrome Treatment Business (2017-2022)
Figure 46. Epygenix Therapeutics Revenue Growth Rate in Dravet Syndrome Treatment Business (2017-2022)
Figure 47. GW Pharmaceuticals Revenue Growth Rate in Dravet Syndrome Treatment Business (2017-2022)
Figure 48. OPKO Health Revenue Growth Rate in Dravet Syndrome Treatment Business (2017-2022)
Figure 49. Zogenix Revenue Growth Rate in Dravet Syndrome Treatment Business (2017-2022)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock